Showing results (171-180 of 223) with videos related to
Sort By:
Pageof 23
Thoracic Cancer|July 18, 2024
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case reportZhicheng Huang, Yadong Wang, Bowen Li, et al.Advanced Materials (Deerfield Beach, Fla.)|November 15, 2024
Low-Spin Fe3+ Evoked by Multiple Defects with Optimal Intermediate Adsorption Attaining Unparalleled Performance in Water OxidationYihao Wang, Shanqing Li, Xu Hou, et al.Thoracic Cancer|November 19, 2024
Clinicopathological features and outcomes of rare lung adenocarcinoma metastasis to the thyroid gland: A single-center, 11-year experienceXuehan Gao, Zhen Cao, Xiayao Diao, et al.Cancers|August 28, 2025
Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case AnalysisXin Du, Xuehan Gao, Jian Cui, et al.Gene|June 24, 2018
Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4Yingzhi Qin, Xiaoyun Zhou, Cheng Huang, et al.BMC Cancer|July 15, 2026
Stage-dependent prognostic value of clinical and pathological T staging in resected lung adenocarcinoma: a multicenter cohort studyLibing Yang, Chao Guo, Xin Du, et al.Frontiers in Immunology|March 31, 2022
Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung CancerHongge Liang, Yan Xu, Minjiang Chen, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 10, 2023
Survival of small-cell lung cancer patients after surgery: A single-center retrospective cohort studyZhibo Zheng, Danyang Zhu, Lei Liu, et al.Annals of Translational Medicine|June 20, 2022
Neoadjuvant immunotherapy followed by surgery with curative intent in 35 patients with advanced NSCLC: the retrospective experiences of a multidisciplinary teamDongjie Ma, Yuan Xu, Yingzhi Qin, et al.Thoracic Cancer|April 24, 2023
Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?Yuan Xu, Dongjie Ma, Yingzhi Qin, et al.Pageof 23